Leah Townsend

Dr. Leah Townsend has a broad foundation in life sciences research and consulting with over 10 years of experience in general human physiology and disease pathology in addition to neurobiology. She has previous experience in both business development and life science consulting including advising life science and biotechnology clients in areas including commercial assessment and strategy, portfolio optimization, and search-based asset identification in therapeutic areas including neurology, gene therapy, stem cell therapy, oncology, bacterial infections, cardiovascular, and rare disease.

Since 2019, Dr. Townsend has utilized her expertise in biotechnology consulting and neuroscience to lead Pulvinar Neuro, which was acquired by EPI in 2022. To date, she has secured $1.2 M in grant funding to facilitate Pulvinar Neuro’s R&D goals and developed numerous academic collaborations.

Dr. Townsend holds a PhD in Neurobiology from the University of North Carolina at Chapel Hill (UNC-CH) as well as both a BS in Psychology (summa cum laude) and BA in Philosophy (cum laude), also from UNC- CH.